2-aminopyrimidine modulators of the histamine H 4 receptor

Details 2-aminopyrimidine modulators of the histamine H 4 receptor 2-aminopyrimidine modulators of the histamine H 4 receptor

2011-04-12

2011-04-12

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S557000

Reexamination Certificate

active

07923451

ABSTRACT:
2-Aminopyrimidine compounds are described, which are useful as H4receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.

REFERENCES:
patent: 3907801 (1975-09-01), Wu et al.
patent: 4980350 (1990-12-01), MacCoss et al.
patent: 5077290 (1991-12-01), Fisher et al.
patent: 5124328 (1992-06-01), Fisher et al.
patent: 5223505 (1993-06-01), Hargreaves et al.
patent: 5470976 (1995-11-01), Humphrey et al.
patent: 5614524 (1997-03-01), Matassa et al.
patent: 5681957 (1997-10-01), Wolters et al.
patent: 5696266 (1997-12-01), Humphrey et al.
patent: 5760623 (1998-06-01), Hastings
patent: 5777134 (1998-07-01), Bakshi et al.
patent: 5817802 (1998-10-01), Humphrey et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 5880139 (1999-03-01), Chang
patent: 5955480 (1999-09-01), Chang
patent: 5998464 (1999-12-01), Bakshi et al.
patent: 6369084 (2002-04-01), Lacombe et al.
patent: 6410526 (2002-06-01), Duggan et al.
patent: 6465462 (2002-10-01), Carling et al.
patent: 7253200 (2007-08-01), Buzard et al.
patent: 7405221 (2008-07-01), Kopka et al.
patent: 2001/0027196 (2001-10-01), Borroni et al.
patent: 2002/0107245 (2002-08-01), Wagle et al.
patent: 2002/0137746 (2002-09-01), Carl et al.
patent: 2006/0051616 (2006-03-01), Suzuki et al.
patent: 2006/0281749 (2006-12-01), Wagle et al.
patent: 2006/0293339 (2006-12-01), Chakravarty et al.
patent: 2007/0065443 (2007-03-01), Tobia et al.
patent: 2007/0185075 (2007-08-01), Bell et al.
patent: 2009/0209571 (2009-08-01), Cote et al.
patent: 2009/0233896 (2009-09-01), Arrington et al.
patent: 2009/0286772 (2009-11-01), Chau et al.
patent: 200968 (1986-11-01), None
patent: 200968 (1990-08-01), None
patent: 1437348 (2004-07-01), None
patent: 1505064 (2005-02-01), None
patent: 1767537 (2007-03-01), None
patent: WO 01/47897 (2001-07-01), None
patent: WO 01/47921 (2001-07-01), None
patent: WO 01/62233 (2001-08-01), None
patent: 0222584 (2002-03-01), None
patent: WO 03/089601 (2003-10-01), None
patent: WO 2004/052862 (2004-06-01), None
patent: WO 2005/054239 (2005-06-01), None
patent: WO 2006/034446 (2006-03-01), None
patent: WO 2006/053109 (2006-05-01), None
patent: WO 2006/065590 (2006-06-01), None
patent: WO 2006/123165 (2006-11-01), None
patent: WO 2007/031529 (2007-03-01), None
patent: WO 2007/090852 (2007-08-01), None
patent: WO 2007/090853 (2007-08-01), None
patent: WO 2007/090854 (2007-08-01), None
patent: WO 2008/008359 (2008-01-01), None
patent: WO 2008/031556 (2008-03-01), None
patent: WO 2008/060766 (2008-05-01), None
patent: WO 2009/068512 (2009-06-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
Dörwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Lespagnol, A. et al. Chim. Therap. 1965, 1, 26-31.
Lespagnol, A. et al. Chim. Therap. 1971, 6(2), 105-108.
Libby, P. Inflammation in atherosclerosis. Nature 2002, 420, 868-874.
Ling, P. et al. Histamine H4receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br. J. Pharmacol. 2004, 142(1), 161-171.
Lippert, U. et al. Human Skin Mast Cells Express H2 and H4, but not H3 Receptors. J. Invest. Dermatol. 2004, 123(1), 116-123.
Liu, C. et al. Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H4) Expressed in Bone Marrow. Mol. Pharmacol. 2001, 59(3), 420-426.
Mashikian, V.M. et al. Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoalveolar lavage fluid of histamine-challenged asthmatic patients. J. Allergy Clin. Immunol. 1998, 101 (6, Part 1), 786-792.
Morse, K.L. et al. Cloning and Characterization of a Novel Human Histamine Receptor. J. Pharmacol. Exp. Ther. 2001, 296(3), 1058-1066.
Nathan, C. Points of control in inflammation. Nature 2002, 420(6917), 846-852.
Ohki, E. et al. Expression of Histamine H4 Receptor in Synovial Cells from Rheumatoid Arthritic Patients. Biol. Pharm. Bull. 2007, 30(11), 2217-2220.
O'Reilly, M. et al. Identification of a H4Receptor on Human Eosinophils—Role in Eosinophil Chemotaxis. J. Recept. Signal Transduction 2002, 22(1-4), 431-448.
Ostercamp, D.L. et al. Rigid Core Vinamidinium Salts and Their N,N′-Rotamers. J. Org. Chem. 2003, 68, 3099-3105.
Pietrzycki, W. et al. Tautomerism and Rotamerism in 2-Methylamino-, 2-Anilino-, 2-Acetamido-, and 2-Benzamidopyridines. Bull. Soc. Chim. Belg. 1993, 102(11-12), 709-717.
Slater, A. et al. Increase in epithelial mast cell numbers in the nasal mucosa of patients with perennial allergic rhinitis. J. Laryngol. Otol. 1996, 110, 929-933.
Steinberg, D. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nature Med. 2002, 8(11), 1211-1217.
Takeshita, K. et al. Critical Role of Histamine H4Receptor in Leukotriene B4Production and Mast Cell-Dependent Neutrophil Recruitment Induced by Zymosan in Vivo. J. Pharmacol. Exp. Ther. 2003, 307(3), 1072-1078.
Thurmond, R.L. et al. A Potent and Selective Histamine H4 Receptor Antagonist with Anti-Inflammatory Properties. J. Pharmacol. Exp. Ther. 2004, 309(1), 404-413.
Thurmond, R.L. et al. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat. Rev. Drug Disc. 2008, 7, 41-53.
Tracey, K.J. The inflammatory reflex. Nature 2002, 420(6917), 853-859.
Varga, C. et al. Inhibitory effects of histamine H4receptor antagonists on experimental colitis in the rat. Eur. J. Pharmacol. 2005, 522(1-3), 130-138.
Voehringer, D. et al. Type 2 Immunity Reflects Orchestrated Recruitment of Cells Committed to IL-4 Production. Immunity 2004, 20(3), 267-277.
Weiner, H.L. et al. Inflammation and therapeutic vaccination in CNS diseases. Nature 2002, 420(6917), 879-884.
Willecomme, B. Annales de Chimie 1969, 4(6), 405-428.
Zhang, M. et al. The Histamine H4 Receptor: A Novel Mediator of Inflammatory and Immune Disorders. Pharmacol. Ther. 2007, 113, 594-606.
Zhang, M. et al. The Histamine H4 Receptor in Autoimmune Disease. Expert Opin. Investig. Drugs 2006, 15(11), 1443-1452.
Amin, K. et al. Inflammation and Structural Changes in the Airways of Patients with Atopic and Nonatopic Asthma. Am. J. Resp. Crit. Care Med. 2000, 162(6), 2295-2301.
Becker, I. J. Het. Chem. 2005, 42(7), 1289-1295.
Bell, J.K. et al. Involvement of histamine H4and H1receptors in scratching induced by histamine receptor agonists in BalbC mice. Br. J. Pharmacol. 2004, 142(2), 374-380.
Benoist, C. et al. Mast cells in autoimmune disease. Nature 2002, 420(6917), 875-878.
Buckland, K.F. et al. Histamine induces cytoskeletal changes in human eosinophils via the H4receptor Br. J. Pharmacol. 2003, 140(6), 1117-1127.
Cholli, A.L. et al. Necessary Conditions for the Welectron Delocalization in Enamino-Type Muscle Relaxants. J. Pharm. Sci. 1993, 82(12), 1275-1280.
Coge, F. et al. Structure and Expression of the Human Histamine H4-Receptor Gene. Biochem. Biophys. Res. Commun. 2001, 284(2), 301-309.
Cohen, J. The immunopathogenesis of sepsis. Nature 2002, 420(6917), 885-891.
Coussens, L.M. et al. Inflammation and cancer. Nature 2002, 420(6917), 860-867.
Crimi, E. et al. Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen. Am. Rev. Respir. Dis. 1991, 144(6), 1282-1286.
de Esch, I.J.P. et al. The histamine H4receptor as a new therapeutic target for inflammation. Trends Pharmacol. Sci. 2005, 26(9), 462-469.
Dunford, P.J. et al. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J. Allergy Clin. Immunol. 2007, 119(1), 176-183.
Fokkens, W.J. et al. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: a biopsy study. Clin. Exp. Allergy 1992, 22(7), 701-710.
Fung-Leung, W.-P. et al. Histamine H4 receptor antagonists: The new antihistamines? Curr. Opin. Invest. Drugs 2004, 5(11), 1174-118

Affiliated with

Also associated with

Rating

2-aminopyrimidine modulators of the histamine H 4 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-aminopyrimidine modulators of the histamine H 4 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aminopyrimidine modulators of the histamine H 4 receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2637841